434 related articles for article (PubMed ID: 16691242)
1. Management of panurothelial disease in superficial bladder cancer.
Srougi M; Antunes AA; Dall'Oglio MF; Cury J
Nat Clin Pract Urol; 2006 May; 3(5):284-8. PubMed ID: 16691242
[TBL] [Abstract][Full Text] [Related]
2. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
[TBL] [Abstract][Full Text] [Related]
3. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
4. Surgically treated transitional cell carcinomas of the bladder. The role of radical surgery.
Al-Ali MA; Kashmoula DM; Haddad LF
Saudi Med J; 2002 Jun; 23(6):695-9. PubMed ID: 12070550
[TBL] [Abstract][Full Text] [Related]
5. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
[TBL] [Abstract][Full Text] [Related]
6. Peritonitis carcinomatosa in a patient with recurrent "superficial" bladder cancer treated with cystectomy and nephroureterectomy.
de Vries RR; Bex A; Horenblas S
Urology; 2007 Jan; 69(1):184.e1-2. PubMed ID: 17270648
[TBL] [Abstract][Full Text] [Related]
7. [Recurrent and up-grading bladder cancer in a young female: a case report].
Ouchi H; Noguchi S; Masuda M; Yao M; Kubota Y; Hosaka M
Hinyokika Kiyo; 1996 Apr; 42(4):311-3. PubMed ID: 8693967
[TBL] [Abstract][Full Text] [Related]
8. [Recurrent transitional cell carcinoma of the bladder in a young woman: report of a case].
Ikeda I; Terao T; Nakagomi K; Masuda M; Hirokawa M
Hinyokika Kiyo; 1992 Nov; 38(11):1261-3. PubMed ID: 1485578
[TBL] [Abstract][Full Text] [Related]
9. Low grade papillary transitional cell carcinoma pelvic recurrence masquerading as high grade invasive carcinoma, ten years after radical cystectomy.
Dangle PP; Wang WP; Mayerson J; Mortazavi A; Monk P
World J Surg Oncol; 2008 Sep; 6():103. PubMed ID: 18826578
[TBL] [Abstract][Full Text] [Related]
10. [Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].
Fujimoto K; Chihara Y; Kondo H; Hirao Y
Hinyokika Kiyo; 2006 Jun; 52(6):433-8. PubMed ID: 16848356
[TBL] [Abstract][Full Text] [Related]
11. The role of repeat transurethral resection in the management of high-risk superficial transitional cell bladder cancer.
Sivalingam S; Probert JL; Schwaibold H
BJU Int; 2005 Oct; 96(6):759-62. PubMed ID: 16153194
[No Abstract] [Full Text] [Related]
12. Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis.
Uchida A; Yonou H; Hayashi E; Iha K; Oda M; Miyazato M; Oshiro Y; Hokama S; Sugaya K; Ogawa Y
Urology; 2007 Feb; 69(2):275-9. PubMed ID: 17320663
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
14. Management of low grade papillary bladder tumors.
Herr HW; Donat SM; Reuter VE
J Urol; 2007 Oct; 178(4 Pt 1):1201-5; discussion 1205. PubMed ID: 17698090
[TBL] [Abstract][Full Text] [Related]
15. [A case of transitional cell carcinoma with squamous differentiation which developed squamous cell carcinoma in situ in the clinical course].
Sugiura S; Makiyama K; Yokomizo Y; Umemoto S; Miyoshi Y; Nakaigawa N; Ogawa T; Uemurai H; Yao M; Kubota Y; Yamanaka S
Hinyokika Kiyo; 2006 Sep; 52(9):715-8. PubMed ID: 17040058
[TBL] [Abstract][Full Text] [Related]
16. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of nonmuscle invasive transitional cell carcinoma of the bladder: how and how often?
Schmidbauer J; Lindenau G
Curr Opin Urol; 2008 Sep; 18(5):504-7. PubMed ID: 18670275
[TBL] [Abstract][Full Text] [Related]
18. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of bladder cancer. II. The fate of patients with T1b transitional cell bladder cancer.
Pagano F; Pegoraro V; Prayer-Galetti T; Pizzarella M; Milani C; Garbeglio A
Eur Urol; 1987; 13(5):305-9. PubMed ID: 3678301
[TBL] [Abstract][Full Text] [Related]
20. [International Consensus Panel--treatment strategies for superficial bladder cancer].
Adler S; St Niclas M
Aktuelle Urol; 2006 Sep; 37(5):320-3; discussion 322-3. PubMed ID: 17004179
[No Abstract] [Full Text] [Related]
[Next] [New Search]